|
|
|
|
| LEADER |
06042nam a22002895i 4500 |
| 001 |
000293013 |
| 005 |
20210609105635.0 |
| 007 |
cr nn 008mamaa |
| 008 |
101222s2011 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781607619598
|
| 024 |
7 |
|
|a 10.1007/978-1-60761-959-8
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Translational Stem Cell Research :
|b Issues Beyond the Debate on the Moral Status of the Human Embryo /
|c edited by Kristina Hug, Göran Hermerén.
|
| 250 |
|
|
|a 1st ed. 2011.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2011.
|
| 300 |
|
|
|a XXVI, 462 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Stem Cell Biology and Regenerative Medicine,
|
| 505 |
0 |
|
|a PREFACE -- BIOSKETCHES -- SECTION I: TRANSLATIONAL STEM CELL RESEARCH: WHAT IS POSSIBLE TODAY AND WHAT STILL REMAINS TO BE ACHIEVED?- Chapter 1. Towards clinical application of stem cells in neurodegenerative disorders (Olle Lindvall and Zaal Kokaia) -- Chapter 2. Treating cardiac disorders with stem cells (Christine Mummery) -- Chapter 3. Treating diabetes (Mattias Hansson and Ole D. Madsen) -- Chapter 4. Treating oncologic diseases (Peter W. Andrews) -- Chapter 5. Clinical application of autologous epithelial stem cells in disorders of squamous epithelia (Nicolas Grasset and Yann Barrandon) -- Chapter 6. Towards a cell therapy for Muscular Dystrophy: technical and ethical issues (Giulio Cossu) -- Chapter 7. Towards modelling and therapy of genetic diseases using pluripotent stem cells (Petr Dvorak) -- Chapter 8. Therapeutic possibilities of induced pluripotent stem cells (Harold Ayetey) -- Chapter 9. Industrial applications of stem cells (Oliver Brüstle, Michael Rossbach and Manal Bosnali) -- Chapter 10. The obstacles on the road to clinical applications of stem cell-based therapies: What has been done to overcome these obstacles and what remains to be done? (Outi Hovatta) -- SECTION II. TRANSLATING STEM CELL RESEARCH KNOWLEDGE FROM BENCH TO BEDSIDE: ETHICAL ISSUES -- Chapter 11. Animal use in translational stem cell research and treatment development: Ethical issues (Kate Millar) -- Chapter 12. Ethical aspects of stem cell-based clinical translation: research, innovation, and delivering unproven interventions (Jeremy Sugarman and Doug Sipp) -- Chapter 13. Translational stem cell research in pediatrics: Ethical issues (Michael Fuchs) -- Chapter 14. Experimental stem cell-based therapy in pediatrics: A fictional case study (Kristina Hug and Anders Castor) -- SECTION III: CREATION OF HUMAN-ANIMAL ENTITIES FOR TRANSLATIONAL STEM CELL RESEARCH: SCIENTIFIC, ETHICAL AND REGULATORY CHALLENGES -- Chapter 15. Creation of human-animal entities for translational stem cell research: Scientific explanation of issues that are often confused (Neville Cobbe and Val Wilson) -- Chapter 16. Creation of human-animal entities for translational stem cell research: Ethical issues (Gisela Badura-Lotter and Marcus Duewell) -- Chapter 17. Chimeras + hybrids = chimbrids: Legal aspects (Jochen Taupitz) -- SECTION IV: STEM CELL BANKING FOR TRANSLATIONAL STEM CELL RESEARCH OR STEM CELL-BASED THERAPIES -- Chapter 18. Stem cell banks: Reality, roles and challenges (Glyn Stacey) -- Chapter 19. Broad consent (Linus Broström and Mats Johansson) -- Chapter 20. Banks, repositories and registries of stem cell lines: The challenges to legal regulation (Mette Hartlev) -- SECTION V: TRANSLATIONAL STEM CELL RESEARCH AND COMMERCIAL FUNDING -- Chapter 21. Proprietary interests and collaboration in stem cell science: Avoiding anticommons, countering canalization (Matthew Herder) -- SECTION VI: PATENTING OF HUMAN STEM CELL-BASED INVENTIONS: SCIENTIFIC, ETHICAL AND REGULATORY ISSUES -- Chapter 22. Legal problems raised by patents on human stem cell-based inventions (Paul L.C. Torremans) -- Chapter 23. Patenting of human stem cell-based inventions: Can there be technological solutions to a moral dilemma? (Aliki Nichogiannopoulou) -- Chapter 24. Patenting of human stem cell-based inventions: Ethical issues including and beyond the morality clause (Göran Hermerén) -- SECTION VII: FROM GENERAL PUBLIC TO RESEARCHERS, AND VICE VERSA: COMMUNICATION ISSUES IN TRANSLATIONAL STEM CELL RESEARCH -- Chapter 25. Ethical, legal and social implications of translational stem cell research: Effects of commercialisation on public opinion and trust of stem cell research (Ubaka Ogbogu and Amy Zarzeczny) -- Chapter 26. Patients’ organisations and their opinions: How much have they been taken into consideration when regulating stem cell research? (Mary Baker and Philip Watson) -- Chapter 27. Communicating translational stem cell research to the general public: Challenges and suggestions (Sébastien Duprat) -- SECTION VIII: TRANSLATIONAL STEM CELL RESEARCH AND ITS PSYCHOLOGICAL IMPLICATIONS -- Chapter 28. Psychosocial and cultural factors affecting judgments and decisions about translational stem cell research (Melissa L. Finucane and Andrew E. Williams) -- SECTION IX: ETHICAL EVALUATION OF TRANSLATIONAL STEM CELL RESEARCH PROJECTS IN RESEARCH ETHICS COMMITTEES -- Chapter 29. Ethics and uncertainty: Considerations for the design and review of translational trials involving stem cells (James Anderson and Jonathan Kimmelman) -- SECTION X: LOOKING AT THE FUTURE OF TRANSLATIONAL STEM CELL RESEARCH AND STEM CELL-BASED THERAPEUTIC APPLICATIONS: RISKS, LONG-TERM EFFECTS AND PRIORITY SETTING -- Chapter 30. Unruhe und Ungeweissenheit – Stem cells and risks (Nils-Eric Sahlin, Johannes Persson and Niklas Vareman) -- Chapter 31. Looking at the future of translational stem cell research and stem cell-based therapeutic applications: Priority setting and social justice (Göran Hermerén).
|
| 650 |
|
0 |
|a Stem cells.
|
| 650 |
1 |
4 |
|a Stem Cells.
|
| 700 |
1 |
|
|a Hug, Kristina.
|e editor.
|
| 700 |
1 |
|
|a Hermerén, Göran.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|